Daiwa Securities Group’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
VPM
VCM
Daiwa Securities Group's TWST Position: Q1 2026 in Review
Daiwa Securities Group sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 210 shares — an estimated $7K sold.
Daiwa Securities Group first reported a position in TWST in Q4 2019 and held it in 25 quarters. The position peaked at $18K in Q3 2021. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.
- Daiwa Securities Group reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 210 Twist Bioscience shares in Q1 2026, an estimated $7K.
- Daiwa Securities Group first reported a position in Twist Bioscience in Q4 2019 and held it in 25 quarters.
- Daiwa Securities Group's Twist Bioscience position peaked at $18K in Q3 2021.
- 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.